Table 1 Baseline investigations

From: Casirivimab-imdevimab monoclonal antibody treatment for an immunocompromised patient with persistent SARS-CoV-2 infection: a case report

Test

Result

Haemoglobin

11.9 g/dl

Total leucocyte count

8.80 thou/µl

Differential count

Neutrophils 50%, Lymphocytes 36%, Monocytes 10, Eosinophils 4%

Platelets

2,19,000/µl

Blood urea nitrogen

10.43 mg/dl

Creatinine

0.86 mg/dl

Sodium

142 mEq/l

Potassium

3.98 mEq/l

Total bilirubin

0.9 mg/dl

Direct bilirubin

0.4 mg/dl

AST/ALT

18/19 IU/L

ALP/GGT

90/34 IU/L

  1. Abbreviations: AST aspartate aminotransferase; ALT alanine aminotransferase; ALP Alkaline phosphatase; GGT Gamma-glutamyl transferase.
  2. SI conversion factors: To convert leukocyte count to 109, multiply by 0.001; haemoglobin to grams per litre, multiply by 10; platelets to 109 /L, multiply by 1.0; urea to millimoles per litre, multiply by 0.357; creatinine to millimoles per litre by 88.4; sodium and potassium to millimoles per litre, multiply by 1; bilirubin to micromoles per litre, multiply by 17.104; ALT, AST to microkatals per litre, multiply by 0.167.